Published in Rev Neurosci on January 01, 2009
Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab (2013) 1.04
Long-term MRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF. PLoS One (2014) 0.91
Aging differentially affects male and female neural stem cell neurogenic properties. Stem Cells Cloning (2010) 0.88
Personalized nanomedicine advancements for stem cell tracking. Adv Drug Deliv Rev (2012) 0.84
Stem Cell-Based Tissue Replacement After Stroke: Factual Necessity or Notorious Fiction? Stroke (2015) 0.83
Intracerebroventricular Transplantation of Cord Blood-Derived Neural Progenitors in a Child With Severe Global Brain Ischemic Injury. Cell Med (2010) 0.79
Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools. Front Neurosci (2015) 0.77
Short-Lived Human Umbilical Cord-Blood-Derived Neural Stem Cells Influence the Endogenous Secretome and Increase the Number of Endogenous Neural Progenitors in a Rat Model of Lacunar Stroke. Mol Neurobiol (2015) 0.76
Overheated and melted intracranial pressure transducer as cause of thermal brain injury during magnetic resonance imaging: case report. J Neurosurg (2012) 1.99
Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther (2005) 1.91
BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther (2004) 1.87
A simple and useful coma scale for patients with neurologic emergencies: the Emergency Coma Scale. Am J Emerg Med (2010) 1.53
Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg (2005) 1.44
Assessment of the difference in posterior circulation involvement between pediatric and adult patients with moyamoya disease. J Neurosurg (2013) 1.42
Exercise exerts neuroprotective effects on Parkinson's disease model of rats. Brain Res (2009) 1.33
Angiogenesis and invasion in glioma. Brain Tumor Pathol (2011) 1.31
Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci (2004) 1.30
Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke (2011) 1.26
The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. J Biol Chem (2004) 1.19
Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci (2010) 1.11
Intravenous route of cell delivery for treatment of neurological disorders: a meta-analysis of preclinical results. Stem Cells Dev (2010) 1.09
Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Ann Neurol (2012) 1.08
In vivo animal stroke models: a rationale for rodent and non-human primate models. Transl Stroke Res (2013) 1.07
Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One (2012) 1.05
Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells. Neurosci Lett (2004) 1.04
Embryonic neural stem cells transplanted in middle cerebral artery occlusion model of rats demonstrated potent therapeutic effects, compared to adult neural stem cells. Brain Res (2008) 1.04
The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol (2004) 1.03
Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines. Mol Cancer Ther (2008) 0.99
Large supratentorial ectopic ependymoma with massive calcification and cyst formation--case report. Neurol Med Chir (Tokyo) (2004) 0.99
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons. BMC Neurosci (2008) 0.98
Detection of seizure-associated high-frequency oscillations above 500Hz. Epilepsy Res (2009) 0.98
Nationwide investigation of the current status of therapeutic neuroendoscopy for ventricular and paraventricular tumors in Japan. J Neurosurg (2011) 0.93
Spinal cord stimulation for the treatment of abnormal posture and gait disorder in patients with Parkinson's disease. Neurol Med Chir (Tokyo) (2012) 0.93
The potential role of vascular endothelial growth factor in the central nervous system. Rev Neurosci (2004) 0.93
Striatal stimulation nurtures endogenous neurogenesis and angiogenesis in chronic-phase ischemic stroke rats. Cell Transplant (2010) 0.92
[Assessment of the signal intensity distribution pattern within the unruptured cerebral aneurysms using color-coded 3D MR angiography]. No Shinkei Geka (2005) 0.92
Cilengitide treatment for malignant glioma: current status and future direction. Neurol Med Chir (Tokyo) (2012) 0.92
Glioblastoma with metastasis to the spleen--case report. Neurol Med Chir (Tokyo) (2003) 0.91
Effects of deferoxamine-activated hypoxia-inducible factor-1 on the brainstem after subarachnoid hemorrhage in rats. Neurosurgery (2008) 0.91
The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model. Brain Res (2005) 0.90
Inhibition of excitatory neuronal cell death by cell-permeable calcineurin autoinhibitory peptide. J Neurochem (2003) 0.90
Neurorescue effects of VEGF on a rat model of Parkinson's disease. Brain Res (2005) 0.89
Posterior decompression of far-out foraminal stenosis caused by a lumbosacral transitional vertebra--case report. Neurol Med Chir (Tokyo) (2011) 0.89
Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas. Neuropathology (2012) 0.89
Influence of perianeurysmal environment on the deformation and bleb formation of the unruptured cerebral aneurysm: assessment with fusion imaging of 3D MR cisternography and 3D MR angiography. AJNR Am J Neuroradiol (2005) 0.89
Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. J Neurosurg (2007) 0.88
Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J Neurosci Res (2002) 0.88
Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application. Cell Transplant (2007) 0.88
Fusion imaging of three-dimensional magnetic resonance cisternograms and angiograms for the assessment of microvascular decompression in patients with hemifacial spasms. J Neurosurg (2007) 0.88
[Surgical and endovascular treatment for superior cerebellar artery aneurysms: report of two cases]. No Shinkei Geka (2013) 0.87
Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas. World Neurosurg (2011) 0.87
Neuroprotective effects of liraglutide for stroke model of rats. Int J Mol Sci (2013) 0.87
Posterior reversible encephalopathy syndrome. J Clin Neurosci (2011) 0.87
Pseudoxanthoma elasticum with carotid rete mirabile. Clin Neurol Neurosurg (2004) 0.87
Identification of glioma-specific RFX4-E and -F isoforms and humoral immune response in patients. Cancer Sci (2005) 0.86
Proteomics-based analysis of invasion-related proteins in malignant gliomas. Neuropathology (2012) 0.86
Epidemiology of dural arteriovenous fistula in Japan: Analysis of Japanese Registry of Neuroendovascular Therapy (JR-NET2). Neurol Med Chir (Tokyo) (2013) 0.85
Rebleeding from a vertebral artery dissecting aneurysm after endovascular internal trapping: adverse effect of intrathecal urokinase injection or incomplete occlusion?-case report-. Neurol Med Chir (Tokyo) (2009) 0.85
Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease. J Neurosurg (2005) 0.85
Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis. Brain Res (2008) 0.85
The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease. Brain Res (2013) 0.84
Toxicity of semaphorin3A for dopaminergic neurons. Neurosci Lett (2005) 0.84
Comparison of the therapeutic potential of adult and embryonic neural precursor cells in a rat model of Parkinson disease. J Neurosurg (2008) 0.84
Reduction of infarct volume and apoptosis by grafting of encapsulated basic fibroblast growth factor-secreting cells in a model of middle cerebral artery occlusion in rats. J Neurosurg (2003) 0.84
Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models. Neuropathology (2012) 0.84
Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease. Acta Med Okayama (2007) 0.84
"Double-stick tape" technique for transposition of an offending vessel in microvascular decompression: technical case report. Neurosurgery (2011) 0.84
A proposal for standardized analysis of the results of microvascular decompression for trigeminal neuralgia and hemifacial spasm. Acta Neurochir (Wien) (2012) 0.83
Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia. J Neurosurg (2005) 0.83
Ex vivo gene therapy: transplantation of neurotrophic factor-secreting cells for cerebral ischemia. Front Biosci (2006) 0.83
Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells. FEBS Lett (2005) 0.83
Percutaneous balloon angioplasty for acute occlusion of intracranial arteries. Neurosurgery (2010) 0.83
Primary germinoma in the medulla oblongata - case report - . Neurol Med Chir (Tokyo) (2011) 0.83
[Training in neurovascular intervention]. No Shinkei Geka (2002) 0.83
Mannitol enhances therapeutic effects of intra-arterial transplantation of mesenchymal stem cells into the brain after traumatic brain injury. Neurosci Lett (2013) 0.82
A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism. J Mol Diagn (2005) 0.82
Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses. Brain Res (2008) 0.82
Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone. Neurosurgery (2010) 0.82
The therapeutic potential of human umbilical cord blood transplantation for neonatal hypoxic-ischemic brain injury and ischemic stroke. Acta Med Okayama (2012) 0.82
Computational fluid dynamics of carotid arteries after carotid endarterectomy or carotid artery stenting based on postoperative patient-specific computed tomography angiography and ultrasound flow data. Neurosurgery (2011) 0.82
[Anti-high mobility group box-1 antibody therapy for traumatic brain injury]. Yakugaku Zasshi (2014) 0.82
Proximal vertebral body fracture after 4-level fusion using l1 as the upper instrumented vertebra for lumbar degenerative disease: report of 2 cases with literature review. Acta Med Okayama (2013) 0.81
Effectiveness of intraoperative near-infrared indocyanine green videoangiography in a case with recurrent spinal perimedullary arteriovenous fistula. Clin Neurol Neurosurg (2010) 0.81
Protein therapy using heme-oxygenase-1 fused to a polyarginine transduction domain attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab (2011) 0.81
Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme. Neurol Med Chir (Tokyo) (2013) 0.81
Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study. J Neurosurg (2003) 0.81
Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat. Brain Res (2006) 0.81
Gene expression profiling of the anti-glioma effect of Cilengitide. Springerplus (2013) 0.81
[Moyamoya disease]. Brain Nerve (2008) 0.81
Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions. Oncol Rep (2004) 0.81
Erythropoietin exerts anti-epileptic effects with the suppression of aberrant new cell formation in the dentate gyrus and upregulation of neuropeptide Y in seizure model of rats. Brain Res (2009) 0.81
Differentiation between intradural and extradural locations of juxta-dural ring aneurysms by using contrast-enhanced 3-dimensional time-of-flight magnetic resonance angiography. Surg Neurol (2007) 0.81
Preoperative simulation for microvascular decompression in patients with idiopathic trigeminal neuralgia: visualization with three-dimensional magnetic resonance cisternogram and angiogram fusion imaging. Neurosurgery (2007) 0.80
Protein transduction method for cerebrovascular disorders. Acta Med Okayama (2009) 0.80
Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion. J Cell Physiol (2011) 0.80
Time course of the diameter of the major cerebral arteries after subarachnoid hemorrhage using corrosion cast technique. Neurol Res (2003) 0.80
[Endovascular coiling of thrombosed basilar tip aneurysm using double stents in a y-configuration]. No Shinkei Geka (2012) 0.79
Fenestration of the supraclinoid internal carotid artery with associated aneurysm. Neurol Med Chir (Tokyo) (2008) 0.79
Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma. Brain Tumor Pathol (2015) 0.79
Infantile cervical intramedullary cavernous angioma manifesting as hematomyelia. Case report. Neurol Med Chir (Tokyo) (2010) 0.79
No pain, no gain: lack of exercise obstructs neurogenesis. Cell Transplant (2015) 0.78
Novel protein transduction method by using 11R: an effective new drug delivery system for the treatment of cerebrovascular diseases. Stroke (2007) 0.78
Adult unilateral moyamoya disease with familial occurrence in two definite cases: a case report and review of the literature. Neurosurg Rev (2005) 0.78
[A case of pineal pure germinoma metastasized to the lumbosacral extradural space 8 years after initial therapy. Case report and review of literature]. No Shinkei Geka (2006) 0.78